Drug
Flutemetamol clinical trials
Also written Vizamyl and AH110690.
- studies test it
- 10
- open now
- 1
- in phase 3
- 6
- first study started
- 2009
Keep track of what changes. Save the flutemetamol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2009 (2)
| Year | Studies |
|---|---|
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 1
- Phase 2
- 2
- Phase 3
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 4
GE Healthcare (6) · Yale University (1) · University of Utah (1) · University Hospital, Toulouse (1) · University of Zurich (1)
Often tested with
Tested in the same studies.
GE-287 (1)
Studies
Open first, then newest update. How each study uses flutemetamol is read from its arms, and is right about nine times in ten.
Testing it · 10
- Flutemetamol F 18 Injection Formulation ComparisonNot yet recruitingPhase 2GE HealthcareNCT07873463Written as Vizamyl
- Parametric Cardiac 18F-flutemetamol PET Imaging in ATTR CardiomyopathyCompletedPhase 1Yale UniversityNCT05374564Written as (18F)Flutemetamol
- Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PETCompletedPhase 2University of UtahNCT01202994Written as 18F-Flutemetamol
- Assessment of Cardiac Fixation During PET Using a New Drug Within Amyloid Cardiac Injuries.TerminatedEarly Phase 1University Hospital, ToulouseNCT03232632Written as PET with 18 F-Flutemetamol
- Investigating the Clinical Consequences of Flutemetamol-PET-scanningTerminatedPhase 3University of ZurichNCT02353949Written as Flutemetamol (Vizamyl)
- Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's DiseaseCompletedPhase 3GE HealthcareNCT01028053Written as Flutemetamol (18F) Injection
- Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) ImagesCompletedPhase 3GE HealthcareNCT01672827Written as [18F]Flutemetamol
- Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure HydrocephalusTerminatedPhase 3GE HealthcareNCT01092546Written as [18F]Flutemetamol
- Positron Emission Tomography (PET) Imaging of Brain Amyloid Compared to Post-Mortem LevelsCompletedPhase 3GE HealthcareNCT01165554Written as [18F] Flutemetamol
- PET Imaging of Brain Amyloid in Normal Pressure HydrocephalusCompletedPhase 3GE HealthcareNCT01053312Written as [18F] Flutemetamol
Given in every arm · 1 — flutemetamol is usual care beside what is tested
Codes
What other systems call flutemetamol · ClinicalTrials.gg INT006291
- MeSH (NLM) C581552flutemetamolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 0F3M7032P5FLUTEMETAMOLConfirmed FDA, NLM, Wikidata
- RxNorm 1486026Confirmed FDA, Wikidata
- Wikidata Q27236700flutemetamolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C90868FlutemetamolOne source FDA
- DrugBank DB15058One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C581552 | flutemetamol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 0F3M7032P5 | FLUTEMETAMOL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1486026 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27236700 | flutemetamol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C90868 | Flutemetamol | One source FDA |
| DrugBank | DB15058 | — | One source Wikidata |
Also registered as flutemetamol f-18 (UNII L49M066S0O · RxNorm 1486025).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.